Skip to main content

Evaxion A/S

EVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001828253

No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.

Superinvestors holding EVAX, Q2 2026

See all superinvestors

No superinvestor reported holding EVAX in Q2 2026.